These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12892861)

  • 1. Apathy in schizophrenia: clinical correlates and association with functional outcome.
    Kiang M; Christensen BK; Remington G; Kapur S
    Schizophr Res; 2003 Sep; 63(1-2):79-88. PubMed ID: 12892861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive and negative symptoms in schizophrenia: different effects on clinical features.
    Rocca P; Bellino S; Calvarese P; Marchiaro L; Patria L; Rasetti R; Bogetto F
    Compr Psychiatry; 2005; 46(4):304-10. PubMed ID: 16175763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apathy, cognitive deficits and functional impairment in schizophrenia.
    Konstantakopoulos G; Ploumpidis D; Oulis P; Patrikelis P; Soumani A; Papadimitriou GN; Politis AM
    Schizophr Res; 2011 Dec; 133(1-3):193-8. PubMed ID: 21788116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.
    Hartmann-Riemer MN; Hager OM; Kirschner M; Bischof M; Kluge A; Seifritz E; Kaiser S
    Schizophr Res; 2015 Dec; 169(1-3):427-432. PubMed ID: 26526750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring motivation in people with schizophrenia.
    Fervaha G; Foussias G; Takeuchi H; Agid O; Remington G
    Schizophr Res; 2015 Dec; 169(1-3):423-426. PubMed ID: 26391283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apathy and the processing of novelty in schizophrenia.
    Roth RM; Koven NS; Pendergrass JC; Flashman LA; McAllister TW; Saykin AJ
    Schizophr Res; 2008 Jan; 98(1-3):232-8. PubMed ID: 17884352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms.
    Stauffer VL; Song G; Kinon BJ; Ascher-Svanum H; Chen L; Feldman PD; Conley RR
    Schizophr Res; 2012 Feb; 134(2-3):195-201. PubMed ID: 22019076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia.
    Horan WP; Blanchard JJ
    Schizophr Res; 2003 Dec; 65(2-3):125-37. PubMed ID: 14630305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinic of apathy in schizophrenia: a critical review of the issue].
    Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
    Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of demotivation and affective disorders in apathy in patients with Parkinson's disease without dementia and depression].
    Delgadillo-Iniguez D; Derouesné C; Lacomblez L; Gély-Nargeot MC
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):197-207. PubMed ID: 23803637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apathy and functioning in first-episode psychosis.
    Faerden A; Friis S; Agartz I; Barrett EA; Nesvåg R; Finset A; Melle I
    Psychiatr Serv; 2009 Nov; 60(11):1495-503. PubMed ID: 19880468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of paliperidone extended-release in schizophrenia patients with prominent affective symptoms.
    Canuso CM; Turkoz I; Sheehan JJ; Bossie CA
    J Affect Disord; 2010 Jan; 120(1-3):193-9. PubMed ID: 19552963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of the concept of apathy: the need for a multifactorial approach in schizophrenia].
    Del-Monte J; Capdevielle D; Gély-Nargeot MC; Yazbek H; Pupier F; Boulenger JP; Raffard S
    Encephale; 2013 May; 39 Suppl 1():S57-63. PubMed ID: 23351930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and clinical, neuropsychological and neuroimaging correlates of apathy following stroke - the Sydney Stroke Study.
    Brodaty H; Sachdev PS; Withall A; Altendorf A; Valenzuela MJ; Lorentz L
    Psychol Med; 2005 Dec; 35(12):1707-16. PubMed ID: 16202190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social adjustment based on reported behaviour in bipolar affective disorder.
    Morriss R; Scott J; Paykel E; Bentall R; Hayhurst H; Johnson T
    Bipolar Disord; 2007; 9(1-2):53-62. PubMed ID: 17391350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits.
    Roth RM; Flashman LA; Saykin AJ; McAllister TW; Vidaver R
    Am J Psychiatry; 2004 Jan; 161(1):157-9. PubMed ID: 14702265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apathy: from symptom to syndrome].
    Drijgers RL; Aalten P; Leentjens AF; Verhey FR
    Tijdschr Psychiatr; 2010; 52(6):397-405. PubMed ID: 20544597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
    Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
    Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social anxiety in outpatients with schizophrenia: a relevant cause of disability.
    Pallanti S; Quercioli L; Hollander E
    Am J Psychiatry; 2004 Jan; 161(1):53-8. PubMed ID: 14702250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.